Keryx takes the cake

Israel’s Keryx Biopharmaceuticals is shepherding a drug through the final stages of U.S. clinical trials that gives hope to the three to four million U.S. diabetes sufferers who experience kidney failure along with their diabetes. Israel’s Keryx Biopharmaceuticals is shepherding …

Israel’s Keryx Biopharmaceuticals is shepherding a drug through the final stages of U.S. clinical trials that gives hope to the three to four million U.S. diabetes sufferers who experience kidney failure along with their diabetes.

Israel’s Keryx Biopharmaceuticals is shepherding a drug through the final stages of U.S. clinical trials that gives hope to the three to four million U.S. diabetes sufferers who experience kidney failure along with their diabetes.